Jefferies Downgrades Boston Scientific to Hold, Lowers Price Target to $46
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsDowngradesPrice TargetHot
Jefferies analyst Matthew Taylor downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $60 to $46.
Jefferies analyst Matthew Taylor downgrades Boston Scientific (NYSE:BSX) from Buy to Hold and lowers the price target from $60 to $46.